GENERAL COMMENTS
-A few minor typographical errors and grammar-sense. Please read through the manuscript carefully again and correct these small errors -Please discuss study limitations -The discussion should include brief details of the larger study planned (e.g. number of patients, outcome measures) REVIEWER Tasilo Bonzel Prof. Dr. med. Klinikum Fulda (retired) REVIEW RETURNED 21-May-2017
I would also ask to consider the citation of relevant previous work in the field.
Reference (1) When the authors write (page 3, line 6) "To FIRST explore..." this reference shows, that at least some work has been done before.
(1 
The design for the evaluation is appropriate. The sample size estimation is clearly defined and correctly calculated. It will be better to consider the potential cluster effect of each study center for sample size estimation and analysis in the next phase based on the current data.
The only improvement need to be considered is the result of outcomes across multi-centers. According to CONSORT, it will be necessary to report the major outcome/s by each center. In the analysis for pooled outcome, it is also essential to include study center as one factor. For categorical outcome, authors can use multiple logistic regression ; for continuous outcome (i.e. AUS), authors can use Analysis of variance. These adjustments will make sure the comparison between heart team group and others are not caused by the potential heterogeneous distributions of heart team group across centers.
VERSION 1 -AUTHOR RESPONSE

REVIEWER: 1 A FEW MINOR TYPOGRAPHICAL ERRORS AND GRAMMAR-SENSE. PLEASE READ THROUGH THE MANUSCRIPT CAREFULLY AGAIN AND CORRECT THESE SMALL ERRORS
We reviewed in detail the whole manuscript and have corrected some typographical errors, including:
• Adding the word "team" after "heart" at page 17, line 9 from the top as well as at page 14 line 2 from the top
• an unnecessary and was removed (pag. 5)
• stenosis was updated to stenoses when necessary
• A typo on legend of Figure 2 "who did not underwent" has been now corrected
PLEASE DISCUSS STUDY LIMITATIONS
This section, also requested by the Editors, have now been expanded and better structured in the dedicated section "strengths and limitations of this study". Specifically two limitations were indicated:
• APACHE, that enrolled patients with stable CAD and diabetes, was intentionally designed to focus on high-risk patients for inappropriate PCI. Therefore true appropriateness of PCI may be underestimated. However, rather than an epidemiological study, APACHE intention was to serve as first initiative sponsored by a national medical society to measure care process and improve quality
• APACHE examined the appropriateness of PCI indication, not of coronary angiography. Therefore we acknowledge as a limitation that we have no data to inform appropriateness of surgical revascularization, nor indication to invasive angiography.
THE DISCUSSION SHOULD INCLUDE BRIEF DETAILS OF THE LARGER STUDY PLANNED (E.G. NUMBER OF PATIENTS, OUTCOME MEASURES)
We thank the reviewer for this important comment. APACHE was truly a first of its kind initiative in Italy and we are now discussing how we can translate in practice what we have learned from these data.
The general consensus is that there is profound lack of multidisciplinary decision-making process that seems to be the first priority. Therefore, we now consider a future initiative addressing this aspect, which we have mentioned in a comment of the revised discussion:
"By quality we intend the degree of match between health care services and the needs they are intended to meet. 20 APACHE was designed to first quantify this match, inform the design of future investigations on this topic (including a planned larger initiative in Italy extended to the whole country designed to develop, implement, and adhere to a shared heart team protocol), and promote a continuous review of practice that may, in turn, inform a more effective, efficient, and equitable resources allocation, and ultimately, better outcomes for patients.
REVIEWER: 2 THIS IS AN IMPORTANT STUDY IN HEALTH CARE RESEARCH. THE STUDY IS METHODOLOGICALLY EXCELLENTLY DONE. THE IMPORTANT QUALITY CHARACTERISTIC IS THE RANDOM ACCESS AND REVIEW OF ORIGINAL PATIENT DOCUMENTS. TO DO THIS NEEDS TIME AND COURAGE OF THE REVIEWERS AND COURAGE OF THE REVIEWED. THE AUTHOR OF THESE COMMENTS HAS (I.A.) PARTICIPATED IN PILOT STUDIES TO REVIEW RANDOMLY SELECTED PAPER DOCUMENTS AND FILMS OF PTCA PATIENTS IN GERMANY (ALKK QUALITY CONTROL PROJECT, NO PUBLICATION) AND IN EUROPE (1) AND PUBLISHED A PAPER ON THE USE AND BENEFITS OF AS HEART TEAM APPROACH (2). ALSO FROM THIS EXPERIENCE, THIS WORK, NOW WITH A TOP DESIGN, IS HIGHLY RELEVANT. I WOULD FAVOR THE AUTHORS TO EXPRESS A GENERAL RECOMMENDATION TO CONTROL THE QUALITY OF INDICATION (AND PERFORMANCE) BY RANDOMLY SELECTED ORIGINAL DOCUMENTS. HOWEVER, I UNDERSTAND THIS APPROACH MAY BE LIMITED BY COSTS AND THE UNWILLINGNESS OF MANY HOSPITALS TO PARTICIPATE.
We thank the reviewer for his important and highly relevant feedback. We confirm indeed the challenges of conducting such a study and concur it is highly desirable a continuing peer review to improve quality. It is important therefore that we find a general consensus on how to do this systematically. Perhaps the review of a random sample of source documentation is more appropriate for a pilot study, including APACHE, while in the future we should aim for a routine analysis of data on PCI as well as coronary angiography (and hopefully surgical revascularization) that has been successfully done in the US with tangible and substantial implications for quality improvement. We have now included both these two relevant references in the revised manuscript as suggested.
Reviewer: 3
THE DESIGN FOR THE EVALUATION IS APPROPRIATE. THE SAMPLE SIZE ESTIMATION IS CLEARLY DEFINED AND CORRECTLY CALCULATED. IT WILL BE BETTER TO CONSIDER THE POTENTIAL CLUSTER EFFECT OF EACH STUDY CENTER FOR SAMPLE SIZE ESTIMATION AND ANALYSIS IN THE NEXT PHASE BASED ON THE CURRENT DATA. THE ONLY IMPROVEMENT NEED TO BE CONSIDERED IS THE RESULT OF OUTCOMES ACROSS MULTI-CENTERS. ACCORDING TO CONSORT, IT WILL BE NECESSARY TO REPORT THE MAJOR OUTCOME/S BY EACH CENTER.
We thank the reviewer for the suggestions on a future study. As recommended, we have now included site-level data for both the primary outcome measure (AUS SITE and AUS CORE) in the new Figure 2 A and B.
IN THE ANALYSIS FOR POOLED OUTCOME, IT IS ALSO ESSENTIAL TO INCLUDE STUDY CENTER AS ONE FACTOR. FOR CATEGORICAL OUTCOME, AUTHORS CAN USE MULTIPLE LOGISTIC REGRESSION; FOR CONTINUOUS OUTCOME (I.E. AUS), AUTHORS CAN USE ANALYSIS OF VARIANCE. THESE ADJUSTMENTS WILL MAKE SURE THE COMPARISON BETWEEN HEART TEAM GROUP AND OTHERS ARE NOT CAUSED BY THE POTENTIAL HETEROGENEOUS DISTRIBUTIONS OF HEART TEAM GROUP ACROSS CENTERS.
We thank the statistical reviewer for this important suggestion. We have now included participating site as a covariate as suggested with AUSSITE and AUSCORE as endpoints.
Considering AUS expresses the same concept as AUC we opted to use only the continuous endpoint for this analysis (so only ANOVA and no logistic regression). In addition, to more comprehensively address this comment we also included the variable on-site cardiac surgery as a covariate, which might have been an important determinant of heart team discussion. Eventually neither participating site nor the presence of cardiac surgery on-site did significantly alter the association between AUS and heart team discussion.
Finally, as suggested in the comment appended in the pdf, we also added 95% confidence intervals to the proportions of the primary outcome measure (AUC) using the normal approximation to the binomial calculation. 
VERSION 2 -REVIEW
REVIEWER
GENERAL COMMENTS
The results are clearly defined and presented which make the results easily reproduced for the second phase which may include more samples, covariates and factors of patients. I only have four minor suggestions to improve the clarity and communications with readers.
1.Please provide the software name and version for the analysis and sample size estimation.
2. The following paragraph is suggested to change "we used ANOVA generalized linear model procedures including participating site and presence of cardiac surgery on-site as a covariates for the key subgroup (factor) of interest (ie. Patients evaluated by the heart team vs not)."
to "we used ANOVA provided in the generalized linear model procedure of SPSS version ?? including participating site and presence of cardiac surgery on-site as co-factors for the key subgroup (factor) of interest (i.e. patients evaluated by the heart team vs not)"
